Talkiatry
PrivateLast Round
Series D
2/12/2026
Total Funding Raised
$452M
Momentum Score
75 /100
Company Overview
Talkiatry is a mental health care company that enhances access to treatment by providing immediate preliminary diagnoses and severity assessments through an interactive, evidence-based process, facilitating connections to in-network quality healthcare.
Sector
Healthcare & Life Sciences
Verticals
Mental Health, Telemedicine
Business Model
B2B2C
Customer Profile
Payment Processing Fee
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Talkiatry Comps
Public and private peers based on sector, stage, and business model.
Talkiatry Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | 2/12/2026 | ||||
| Series C | 6/18/2024 | ||||
| Series B | 7/1/2022 | ||||
| Series A Extension | 1/27/2022 | ||||
| Series A Extension | 7/28/2021 | ||||
Series A | 2/16/2021 |
Key People
Founding team and executive leadership
Talkiatry Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Series D, Series C |
| Perceptive Advisors | Series C, Series D |
| Park Ventures | Series A Extension |
| Sofina S.A. | Series D |
| Left Lane Capital | Series D, Series C, Series B, Series A Extension |
| blisce/ | Series D, Series C, Series B |
| Relevance Ventures | Series A Extension, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 9, 2026
Launched Talkiatry Connect for faster psychiatric referrals.
- Mar 30, 2026
New strategy to improve visibility on AI answer engines.
Talkiatry Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Talkiatry's valuation, stock price, and market status.